Switch theme
Sign up to access all valuation multiples
Baxter International Inc offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
1931
38K+
LTM Revenue $10.8B
LTM EBITDA $2.2B
$26.5B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Baxter International has a last 12-month revenue of $10.8B and a last 12-month EBITDA of $2.2B.
In the most recent fiscal year, Baxter International achieved revenue of $10.6B and an EBITDA of $1.1B.
Baxter International expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Baxter International valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $14.8B | $10.6B | XXX | XXX | XXX |
| Gross Profit | $5.4B | $5.0B | XXX | XXX | XXX |
| Gross Margin | 36% | 47% | XXX | XXX | XXX |
| EBITDA | $1.7B | $1.1B | XXX | XXX | XXX |
| EBITDA Margin | 11% | 10% | XXX | XXX | XXX |
| Net Profit | -$2.4B | $2.7B | XXX | XXX | XXX |
| Net Margin | -16% | 25% | XXX | XXX | XXX |
| Net Debt | $14.9B | $10.6B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 18, 2025, Baxter International's stock price is $29.
Baxter International has current market cap of $14.8B, and EV of $26.5B.
See Baxter International trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $26.5B | $14.8B | XXX | XXX | XXX | XXX | $2.07 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 18, 2025, Baxter International has market cap of $14.8B and EV of $26.5B.
Baxter International's trades at 2.5x LTM EV/Revenue multiple, and 11.8x LTM EBITDA.
Analysts estimate Baxter International's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Baxter International and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $26.5B | XXX | XXX | XXX |
| EV/Revenue | 2.5x | XXX | XXX | XXX |
| EV/EBITDA | 23.7x | XXX | XXX | XXX |
| P/E | -22.8x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 47.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpBaxter International's NTM/LTM revenue growth is 5%
Baxter International's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Baxter International's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Baxter International's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Baxter International and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -28% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -33% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 15% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 28% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 6% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 33% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Baxter International acquired XXX companies to date.
Last acquisition by Baxter International was XXXXXXXX, XXXXX XXXXX XXXXXX . Baxter International acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Baxter International founded? | Baxter International was founded in 1931. |
| Where is Baxter International headquartered? | Baxter International is headquartered in United States of America. |
| How many employees does Baxter International have? | As of today, Baxter International has 38K+ employees. |
| Who is the CEO of Baxter International? | Baxter International's CEO is Mr. D. Brent Shafer. |
| Is Baxter International publicy listed? | Yes, Baxter International is a public company listed on NYS. |
| What is the stock symbol of Baxter International? | Baxter International trades under BAX ticker. |
| When did Baxter International go public? | Baxter International went public in 1961. |
| Who are competitors of Baxter International? | Similar companies to Baxter International include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Baxter International? | Baxter International's current market cap is $14.8B |
| What is the current revenue of Baxter International? | Baxter International's last 12-month revenue is $10.8B. |
| What is the current EBITDA of Baxter International? | Baxter International's last 12-month EBITDA is $2.2B. |
| What is the current EV/Revenue multiple of Baxter International? | Current revenue multiple of Baxter International is 2.5x. |
| What is the current EV/EBITDA multiple of Baxter International? | Current EBITDA multiple of Baxter International is 11.8x. |
| What is the current revenue growth of Baxter International? | Baxter International revenue growth between 2023 and 2024 was -28%. |
| Is Baxter International profitable? | Yes, Baxter International is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
